Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Klimowicz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Pathology|April 22, 2026
Next-gen disease profiling by integrating histopathology with spatial multi-omics dataPriyank Patel, Alexander Klimowicz
Molecular Cancer|August 27, 2015
Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survivalSatbir Thakur, Arash Nabbi, Alexander Klimowicz, et al.
Plos One|June 14, 2021
Deep learning for discovering pathological continuum of crypts and evaluating therapeutic effects: An implication for in vivo preclinical studyDechao Shan, Jie Zheng, Alexander Klimowicz, et al.
Micron (Oxford, England : 1993)|August 25, 2014
Digital differentiation of non-small cell carcinomas of the lung by the fractal dimension of their epithelial architectureLik Hang Lee, Mauro Tambasco, Shannon Otsuka, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumorsNigel Brockton, Joseph Dort, Harold Lau, et al.
Oncotarget|June 26, 2014
Reduced ING1 levels in breast cancer promotes metastasisSatbir Thakur, Arvind K Singla, Jie Chen, et al.
Plos One|January 28, 2021
CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patientsAndrea S Fung, Karen Kopciuk, Michelle L Dean, et al.
Blood|September 16, 2011
Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitorsPaola Neri, Li Ren, Kathy Gratton, et al.
Cancer Research|August 23, 2015
The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast CancersStéphanie Légaré, Luca Cavallone, Aline Mamo, et al.
Oncotarget|March 2, 2018
Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancerAleksi Suo, Allison Childers, Adrijana D'Silva, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Pathology|April 22, 2026
Next-gen disease profiling by integrating histopathology with spatial multi-omics dataPriyank Patel, Alexander Klimowicz
Molecular Cancer|August 27, 2015
Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survivalSatbir Thakur, Arash Nabbi, Alexander Klimowicz, et al.
Plos One|June 14, 2021
Deep learning for discovering pathological continuum of crypts and evaluating therapeutic effects: An implication for in vivo preclinical studyDechao Shan, Jie Zheng, Alexander Klimowicz, et al.
Micron (Oxford, England : 1993)|August 25, 2014
Digital differentiation of non-small cell carcinomas of the lung by the fractal dimension of their epithelial architectureLik Hang Lee, Mauro Tambasco, Shannon Otsuka, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumorsNigel Brockton, Joseph Dort, Harold Lau, et al.
Oncotarget|June 26, 2014
Reduced ING1 levels in breast cancer promotes metastasisSatbir Thakur, Arvind K Singla, Jie Chen, et al.
Plos One|January 28, 2021
CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patientsAndrea S Fung, Karen Kopciuk, Michelle L Dean, et al.
Blood|September 16, 2011
Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitorsPaola Neri, Li Ren, Kathy Gratton, et al.
Cancer Research|August 23, 2015
The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast CancersStéphanie Légaré, Luca Cavallone, Aline Mamo, et al.
Oncotarget|March 2, 2018
Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancerAleksi Suo, Allison Childers, Adrijana D'Silva, et al.
Pageof 2